Prognostic value of primary tumor SUV<sub>max</sub> on pre-treatment <sup>18</sup>F-FDG PET/CT imaging in patients with stage iii non-small cell lung cancer.

Yilmaz, U; Batum, Ö; Koparal, H; Özbilek, E; Kirakli, E

Prognostic value of primary tumor SUV_max on pre-treatment ¹⁸F-FDG PET/CT imaging in patients with stage iii non-small cell lung cancer. / Valor pronóstico del SUV_máx del tumor primario pretratamiento con PET/TC con ¹⁸F-FDG en pacientes con cáncer de pulmón no microcítico en estadio iii.

Yilmaz, U; Batum, Ö; Koparal, H; Özbilek, E; Kirakli, E.

Affiliation

Yilmaz U; Department of Pulmonology, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Izmir, Turquía. Electronic address: ufukyilmazdr@gmail.com.
Batum Ö; Department of Pulmonology, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Izmir, Turquía.
Koparal H; Department of Nuclear Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Izmir, Turquía.
Özbilek E; Department of Nuclear Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Izmir, Turquía.
Kirakli E; Department of Radiation Oncology, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Izmir, Turquía.

Rev Esp Med Nucl Imagen Mol (Engl Ed) ; 2018 03 17.

Article de En, Es | MEDLINE | ID: mdl-29559214

Mots clés

(18)F-FDG PET/CT; (18)F-FDG PET/TC; Chemoradiotherapy; Cáncer de pulmón; Lung cancer; Prognosis; Pronóstico; Quimiorradioterapia

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En / Es Journal: Rev Esp Med Nucl Imagen Mol (Engl Ed) Année: 2018 Type de document: Article Pays de publication: Espagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google